How did Maxcyte's revenue and expenses trend in Q4 2024?

Maxcyte's revenue and expenses in Q4 2024 showed a decline in revenue and an increase in expenses, resulting in a negative net income. 1. **Revenue Trend**: Maxcyte's revenue for Q4 2024 was $21.09 million, $16.41 million, $15.29 million, $13.77 million, $1.13 million, and $868,000 for different business segments. The highest revenue was from product sales, but the overall trend showed a decrease in revenue compared to previous quarters. 2. **Expense Trend**: The company's operating expenses were $4.61 million, and it had R&D expenses and selling, general, and administrative expenses amounting to $14.7 million. These expenses were consistent across different business segments, indicating a fixed cost structure. 3. **Net Income**: The net income for Q4 2024 was -$10.6 million, which suggests that the company had a significant loss in the quarter. This loss can be attributed to the decline in revenue and the high expenses, particularly the selling, general, and administrative expenses. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |MXCT|MXCT.O|Maxcyte|20240101-2024|Leased Elements|1.6412E7|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Other|868000|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Other|452000|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Other|223000|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Product Sales|5361000|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Other|223000|185| |MXCT|MXCT.O|Maxcyte|20240101-2024|Leased Elements|5758000|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |MXCT|MXCT.O|Maxcyte|2024 Q1|12.460944679286897|-9526000|185| |MXCT|MXCT.O|Maxcyte|2024 Q2|10.8162100456621|-9375000|185| |MXCT|MXCT.O|Maxcyte|2024 Q3|-2.71975824371167|-1.1557E7|185| |MXCT|MXCT.O|Maxcyte|2024 Q4|-100.77680939749905|-1.0597E7|185| |code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code| |---|---|---|---|---|---|---| |MXCT|MXCT.O|Maxcyte|2024 Q1|6678000|10.434926409789979|185| |MXCT|MXCT.O|Maxcyte|2024 Q2|5619000|-0.7944915254237288|185| |MXCT|MXCT.O|Maxcyte|2024 Q3|5316000|-15.134099616858238|185| |MXCT|MXCT.O|Maxcyte|2024 Q4|4614000|-21.020198562136255|185| |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Selling, General, and Administrative Expenses YoY|market_code| |---|---|---|---|---|---|---| |MXCT|MXCT.O|Maxcyte|20240331|1.5536E7|5.636771605357993|185| |MXCT|MXCT.O|Maxcyte|20240630|1.529E7|1.4194746617139824|185| |MXCT|MXCT.O|Maxcyte|20240930|1.4973E7|0.4966776293710987|185| |MXCT|MXCT.O|Maxcyte|20241231|1.4699E7|-10.075859537501529|185|